Harrow to Present at Two Investor Conferences in December

Rhea-AI Summary

Harrow (Nasdaq: HROW) announced management will present at two investor conferences in December 2025.

Events and formats:

• BTIG 5th Annual Ophthalmology Day (virtual) — fireside chat on Monday, December 1, 2025 at 8:30 AM ET.
• Piper Sandler 37th Annual Healthcare Conference (New York, NY) — fireside chat on Tuesday, December 2, 2025 at 3:00 PM ET. The Piper Sandler talk will be webcast live on the company website and a replay will be available for approximately 90 days.

News Market Reaction – HROW

+0.23%

1 alert

+0.23% News Effect

On the day this news was published, HROW gained 0.23%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NASHVILLE, Tenn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will participate in the following two investor conferences in December:

BTIG 5^th Annual Ophthalmology Day (Virtual)
Format: Fireside chat
Date/Time: Monday, December 1, 2025, at 8:30 AM EST

Piper Sandler 37^th Annual Healthcare Conference (New York, NY)
Format: Fireside chat
Date/Time: Tuesday, December 2, 2025, at 3:00 PM EST

The fireside chat at Piper Sandler will be webcast live and can be found on the Event’s page on the Company’s website. A replay will be available for approximately 90 days following the event.

About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com.

Contacts:
Mike Biega
Vice President of Investor Relations and Communications        
mbiega@harrowinc.com         
617-913-8890

FAQ

When will Harrow (HROW) present at BTIG 5th Annual Ophthalmology Day?

Harrow management will present at the virtual BTIG event on Monday, December 1, 2025 at 8:30 AM ET.

When and where is Harrow (HROW) speaking at the Piper Sandler 37th Annual Healthcare Conference?

Harrow will speak at Piper Sandler in New York on Tuesday, December 2, 2025 at 3:00 PM ET as a fireside chat.

Will Harrow's Piper Sandler presentation for HROW be available to watch later?

Yes. The Piper Sandler fireside chat will be webcast live and a replay will be available on the company's website for about 90 days.

How can investors watch Harrow (HROW) live webcasts and replays?

Investors can access the live webcast and replay via the Events page on Harrow's investor relations website.

What topics will Harrow (HROW) discuss at the December 2025 investor conferences?

The announcements state the company will participate in fireside chats; specific presentation topics are not detailed.